Literature DB >> 2195558

Histamine receptors: subclasses and specific ligands.

E E Haaksma1, R Leurs, H Timmerman.   

Abstract

In this review the three main types of histamine receptors are discussed together with their specific ligands. For the classical H1-receptors much emphasis is put on the mechanism by which the receptor is stimulated. For the H1- and H2-receptor the review includes information on the several models available for establishing agonistic or antagonistic activity. In the section on the H3-receptor the ligands are discussed as well as the possible physiological role of this receptor. In the final paragraphs some less well defined activities are presented.

Mesh：

Substances：

Year:  1990        PMID： 2195558     DOI： 10.1016/0163-7258(90)90046-5

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN： 0163-7258            Impact factor:   12.310


  13 in total

Review 1.  New insights into the second generation antihistamines.

Authors:  G M Walsh; L Annunziato; N Frossard; K Knol; S Levander; J M Nicolas; M Taglialatela; M D Tharp; J P Tillement; H Timmerman
Journal:  Drugs       Date:  2001       Impact factor: 9.546

2.  Short-term desensitization of the histamine H1 receptor in human HeLa cells: involvement of protein kinase C dependent and independent pathways.

Authors:  M J Smit; S M Bloemers; R Leurs; L G Tertoolen; A Bast; S W de Laat; H Timmerman
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

Review 3.  Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendations.

Authors:  Anja Cerovecki; Richard Musil; Ansgar Klimke; Florian Seemüller; Ekkehard Haen; Rebecca Schennach; Kai-Uwe Kühn; Hans-Peter Volz; Michael Riedel
Journal:  CNS Drugs       Date:  2013-07       Impact factor: 5.749

4.  Medial vestibular nucleus in the guinea-pig: histaminergic receptors. I. An in vitro study.

Authors:  M Serafin; A Khateb; N Vibert; P P Vidal; M Mühlethaler
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

Review 5.  Intestinal epithelial function: the case for immunophysiological regulation. Implications for disease (2).

Authors:  D M McKay; M H Perdue
Journal:  Dig Dis Sci       Date:  1993-09       Impact factor: 3.199

6.  Histamine H3 Inverse Agonist BF 2649 or Antagonist with Partial H4 Agonist Activity Clobenpropit Reduces Amyloid Beta Peptide-Induced Brain Pathology in Alzheimer's Disease.

Authors:  Ranjana Patnaik; Aruna Sharma; Stephen D Skaper; Dafin F Muresanu; José Vicente Lafuente; Rudy J Castellani; Ala Nozari; Hari S Sharma
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

7.  Inhibition of noradrenaline release from the sympathetic nerves of the human saphenous vein by presynaptic histamine H3 receptors.

Authors:  G J Molderings; G Weissenborn; E Schlicker; J Likungu; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-07       Impact factor: 3.000

8.  All-or-nothing Ca2+ mobilization from the intracellular stores of single histamine-stimulated HeLa cells.

Authors:  M D Bootman; M J Berridge; C W Taylor
Journal:  J Physiol       Date:  1992-05       Impact factor: 5.182

9.  The new potent and selective histamine H2 receptor agonist amthamine as a tool to study gastric secretion.

Authors:  G Coruzzi; H Timmerman; M Adami; G Bertaccini
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-07       Impact factor: 3.000

10.  Involvement of histamine H4 and H1 receptors in scratching induced by histamine receptor agonists in Balb C mice.

Authors:  J K Bell; D S McQueen; J L Rees
Journal:  Br J Pharmacol       Date:  2004-04-05       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.